3D Medicines

About:

3D Medicines mission is to improve people’s health through cancer personalized diagnostics and treatment.

Top Investors: Haier, China Capital Management, China Capital Investment Group, Fang Fund Partners, CTS Capital

Description:

3D Medicines, we use individual’s genetic information to prevent, diagnose, and treat cancer. We develop personalized medicines according to target population’s genetic background, to increase efficacy and safety.

Total Funding Amount:

$506M

Headquarters Location:

Minhang, Shanghai, China

Founded Date:

2010-01-01

Contact Email:

marketing(AT)3dmedcare.com

Founders:

John Gong, Simon Shung

Number of Employees:

501-1000

Last Funding Date:

2020-11-01

IPO Status:

Public

Industries: